Sickle Cell Disease Treatments Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sickle Cell Disease Treatments Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 Infection Prevention with Vaccination and Antibiotics
1.2.3 Blood Transfusion
1.2.4 The Medication Hydroxycarbamide
1.2.5 A Transplant of Bone Marrow Cells
1.3 Market by Application
1.3.1 Global Sickle Cell Disease Treatments Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Sickle Cell Disease Treatments Market Perspective (2018-2030)
2.2 Sickle Cell Disease Treatments Growth Trends by Region
2.2.1 Sickle Cell Disease Treatments Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Sickle Cell Disease Treatments Historic Market Size by Region (2018-2023)
2.2.3 Sickle Cell Disease Treatments Forecasted Market Size by Region (2023-2030)
2.3 Sickle Cell Disease Treatments Market Dynamics
2.3.1 Sickle Cell Disease Treatments Industry Trends
2.3.2 Sickle Cell Disease Treatments Market Drivers
2.3.3 Sickle Cell Disease Treatments Market Challenges
2.3.4 Sickle Cell Disease Treatments Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sickle Cell Disease Treatments Players by Revenue
3.1.1 Global Top Sickle Cell Disease Treatments Players by Revenue (2018-2023)
3.1.2 Global Sickle Cell Disease Treatments Revenue Market Share by Players (2018-2023)
3.2 Global Sickle Cell Disease Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sickle Cell Disease Treatments Revenue
3.4 Global Sickle Cell Disease Treatments Market Concentration Ratio
3.4.1 Global Sickle Cell Disease Treatments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Disease Treatments Revenue in 2022
3.5 Sickle Cell Disease Treatments Key Players Head office and Area Served
3.6 Key Players Sickle Cell Disease Treatments Product Solution and Service
3.7 Date of Enter into Sickle Cell Disease Treatments Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sickle Cell Disease Treatments Breakdown Data by Type
4.1 Global Sickle Cell Disease Treatments Historic Market Size by Type (2018-2023)
4.2 Global Sickle Cell Disease Treatments Forecasted Market Size by Type (2023-2030)
5 Sickle Cell Disease Treatments Breakdown Data by Application
5.1 Global Sickle Cell Disease Treatments Historic Market Size by Application (2018-2023)
5.2 Global Sickle Cell Disease Treatments Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Sickle Cell Disease Treatments Market Size (2018-2030)
6.2 North America Sickle Cell Disease Treatments Market Size by Country (2018-2023)
6.3 North America Sickle Cell Disease Treatments Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Sickle Cell Disease Treatments Market Size (2018-2030)
7.2 Europe Sickle Cell Disease Treatments Market Size by Country (2018-2023)
7.3 Europe Sickle Cell Disease Treatments Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sickle Cell Disease Treatments Market Size (2018-2030)
8.2 Asia-Pacific Sickle Cell Disease Treatments Market Size by Country (2018-2023)
8.3 Asia-Pacific Sickle Cell Disease Treatments Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Sickle Cell Disease Treatments Market Size (2018-2030)
9.2 Latin America Sickle Cell Disease Treatments Market Size by Country (2018-2023)
9.3 Latin America Sickle Cell Disease Treatments Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sickle Cell Disease Treatments Market Size (2018-2030)
10.2 Middle East & Africa Sickle Cell Disease Treatments Market Size by Country (2018-2023)
10.3 Middle East & Africa Sickle Cell Disease Treatments Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Sickle Cell Disease Treatments Introduction
11.1.4 AstraZeneca Revenue in Sickle Cell Disease Treatments Business (2018-2023)
11.1.5 AstraZeneca Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Detail
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Sickle Cell Disease Treatments Introduction
11.2.4 Eli Lilly Revenue in Sickle Cell Disease Treatments Business (2018-2023)
11.2.5 Eli Lilly Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Sickle Cell Disease Treatments Introduction
11.3.4 Bristol-Myers Squibb Revenue in Sickle Cell Disease Treatments Business (2018-2023)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Sickle Cell Disease Treatments Introduction
11.4.4 Novartis Revenue in Sickle Cell Disease Treatments Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Sickle Cell Disease Treatments Introduction
11.5.4 Pfizer Revenue in Sickle Cell Disease Treatments Business (2018-2023)
11.5.5 Pfizer Recent Development
11.6 Baxter
11.6.1 Baxter Company Detail
11.6.2 Baxter Business Overview
11.6.3 Baxter Sickle Cell Disease Treatments Introduction
11.6.4 Baxter Revenue in Sickle Cell Disease Treatments Business (2018-2023)
11.6.5 Baxter Recent Development
11.7 Emmaus Life Sciences
11.7.1 Emmaus Life Sciences Company Detail
11.7.2 Emmaus Life Sciences Business Overview
11.7.3 Emmaus Life Sciences Sickle Cell Disease Treatments Introduction
11.7.4 Emmaus Life Sciences Revenue in Sickle Cell Disease Treatments Business (2018-2023)
11.7.5 Emmaus Life Sciences Recent Development
11.8 Bluebird Bio
11.8.1 Bluebird Bio Company Detail
11.8.2 Bluebird Bio Business Overview
11.8.3 Bluebird Bio Sickle Cell Disease Treatments Introduction
11.8.4 Bluebird Bio Revenue in Sickle Cell Disease Treatments Business (2018-2023)
11.8.5 Bluebird Bio Recent Development
11.9 Global Blood Therapeutics
11.9.1 Global Blood Therapeutics Company Detail
11.9.2 Global Blood Therapeutics Business Overview
11.9.3 Global Blood Therapeutics Sickle Cell Disease Treatments Introduction
11.9.4 Global Blood Therapeutics Revenue in Sickle Cell Disease Treatments Business (2018-2023)
11.9.5 Global Blood Therapeutics Recent Development
11.10 Sangamo Therapeutics
11.10.1 Sangamo Therapeutics Company Detail
11.10.2 Sangamo Therapeutics Business Overview
11.10.3 Sangamo Therapeutics Sickle Cell Disease Treatments Introduction
11.10.4 Sangamo Therapeutics Revenue in Sickle Cell Disease Treatments Business (2018-2023)
11.10.5 Sangamo Therapeutics Recent Development
11.11 Acceleron Pharma
11.11.1 Acceleron Pharma Company Detail
11.11.2 Acceleron Pharma Business Overview
11.11.3 Acceleron Pharma Sickle Cell Disease Treatments Introduction
11.11.4 Acceleron Pharma Revenue in Sickle Cell Disease Treatments Business (2018-2023)
11.11.5 Acceleron Pharma Recent Development
11.12 Arena Pharmaceuticals
11.12.1 Arena Pharmaceuticals Company Detail
11.12.2 Arena Pharmaceuticals Business Overview
11.12.3 Arena Pharmaceuticals Sickle Cell Disease Treatments Introduction
11.12.4 Arena Pharmaceuticals Revenue in Sickle Cell Disease Treatments Business (2018-2023)
11.12.5 Arena Pharmaceuticals Recent Development
11.13 Alnylam Pharmaceuticals
11.13.1 Alnylam Pharmaceuticals Company Detail
11.13.2 Alnylam Pharmaceuticals Business Overview
11.13.3 Alnylam Pharmaceuticals Sickle Cell Disease Treatments Introduction
11.13.4 Alnylam Pharmaceuticals Revenue in Sickle Cell Disease Treatments Business (2018-2023)
11.13.5 Alnylam Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Sickle Cell Disease Treatments Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2030
Table 2. Key Players of Infection Prevention with Vaccination and Antibiotics
Table 3. Key Players of Blood Transfusion
Table 4. Key Players of The Medication Hydroxycarbamide
Table 5. Key Players of A Transplant of Bone Marrow Cells
Table 6. Global Sickle Cell Disease Treatments Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2030
Table 7. Global Sickle Cell Disease Treatments Market Size by Region (US$ Million): 2018 VS 2022 VS 2030
Table 8. Global Sickle Cell Disease Treatments Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Sickle Cell Disease Treatments Market Share by Region (2018-2023)
Table 10. Global Sickle Cell Disease Treatments Forecasted Market Size by Region (2023-2030) & (US$ Million)
Table 11. Global Sickle Cell Disease Treatments Market Share by Region (2023-2030)
Table 12. Sickle Cell Disease Treatments Market Trends
Table 13. Sickle Cell Disease Treatments Market Drivers
Table 14. Sickle Cell Disease Treatments Market Challenges
Table 15. Sickle Cell Disease Treatments Market Restraints
Table 16. Global Sickle Cell Disease Treatments Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Sickle Cell Disease Treatments Market Share by Players (2018-2023)
Table 18. Global Top Sickle Cell Disease Treatments Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Disease Treatments as of 2022)
Table 19. Ranking of Global Top Sickle Cell Disease Treatments Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Sickle Cell Disease Treatments Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Sickle Cell Disease Treatments Product Solution and Service
Table 23. Date of Enter into Sickle Cell Disease Treatments Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Sickle Cell Disease Treatments Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Sickle Cell Disease Treatments Revenue Market Share by Type (2018-2023)
Table 27. Global Sickle Cell Disease Treatments Forecasted Market Size by Type (2023-2030) & (US$ Million)
Table 28. Global Sickle Cell Disease Treatments Revenue Market Share by Type (2023-2030)
Table 29. Global Sickle Cell Disease Treatments Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Sickle Cell Disease Treatments Revenue Market Share by Application (2018-2023)
Table 31. Global Sickle Cell Disease Treatments Forecasted Market Size by Application (2023-2030) & (US$ Million)
Table 32. Global Sickle Cell Disease Treatments Revenue Market Share by Application (2023-2030)
Table 33. North America Sickle Cell Disease Treatments Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Sickle Cell Disease Treatments Market Size by Country (2023-2030) & (US$ Million)
Table 35. Europe Sickle Cell Disease Treatments Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Sickle Cell Disease Treatments Market Size by Country (2023-2030) & (US$ Million)
Table 37. Asia-Pacific Sickle Cell Disease Treatments Market Size by Region (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Sickle Cell Disease Treatments Market Size by Region (2023-2030) & (US$ Million)
Table 39. Latin America Sickle Cell Disease Treatments Market Size by Country (2018-2023) & (US$ Million)
Table 40. Latin America Sickle Cell Disease Treatments Market Size by Country (2023-2030) & (US$ Million)
Table 41. Middle East & Africa Sickle Cell Disease Treatments Market Size by Country (2018-2023) & (US$ Million)
Table 42. Middle East & Africa Sickle Cell Disease Treatments Market Size by Country (2023-2030) & (US$ Million)
Table 43. AstraZeneca Company Detail
Table 44. AstraZeneca Business Overview
Table 45. AstraZeneca Sickle Cell Disease Treatments Product
Table 46. AstraZeneca Revenue in Sickle Cell Disease Treatments Business (2018-2023) & (US$ Million)
Table 47. AstraZeneca Recent Development
Table 48. Eli Lilly Company Detail
Table 49. Eli Lilly Business Overview
Table 50. Eli Lilly Sickle Cell Disease Treatments Product
Table 51. Eli Lilly Revenue in Sickle Cell Disease Treatments Business (2018-2023) & (US$ Million)
Table 52. Eli Lilly Recent Development
Table 53. Bristol-Myers Squibb Company Detail
Table 54. Bristol-Myers Squibb Business Overview
Table 55. Bristol-Myers Squibb Sickle Cell Disease Treatments Product
Table 56. Bristol-Myers Squibb Revenue in Sickle Cell Disease Treatments Business (2018-2023) & (US$ Million)
Table 57. Bristol-Myers Squibb Recent Development
Table 58. Novartis Company Detail
Table 59. Novartis Business Overview
Table 60. Novartis Sickle Cell Disease Treatments Product
Table 61. Novartis Revenue in Sickle Cell Disease Treatments Business (2018-2023) & (US$ Million)
Table 62. Novartis Recent Development
Table 63. Pfizer Company Detail
Table 64. Pfizer Business Overview
Table 65. Pfizer Sickle Cell Disease Treatments Product
Table 66. Pfizer Revenue in Sickle Cell Disease Treatments Business (2018-2023) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Baxter Company Detail
Table 69. Baxter Business Overview
Table 70. Baxter Sickle Cell Disease Treatments Product
Table 71. Baxter Revenue in Sickle Cell Disease Treatments Business (2018-2023) & (US$ Million)
Table 72. Baxter Recent Development
Table 73. Emmaus Life Sciences Company Detail
Table 74. Emmaus Life Sciences Business Overview
Table 75. Emmaus Life Sciences Sickle Cell Disease Treatments Product
Table 76. Emmaus Life Sciences Revenue in Sickle Cell Disease Treatments Business (2018-2023) & (US$ Million)
Table 77. Emmaus Life Sciences Recent Development
Table 78. Bluebird Bio Company Detail
Table 79. Bluebird Bio Business Overview
Table 80. Bluebird Bio Sickle Cell Disease Treatments Product
Table 81. Bluebird Bio Revenue in Sickle Cell Disease Treatments Business (2018-2023) & (US$ Million)
Table 82. Bluebird Bio Recent Development
Table 83. Global Blood Therapeutics Company Detail
Table 84. Global Blood Therapeutics Business Overview
Table 85. Global Blood Therapeutics Sickle Cell Disease Treatments Product
Table 86. Global Blood Therapeutics Revenue in Sickle Cell Disease Treatments Business (2018-2023) & (US$ Million)
Table 87. Global Blood Therapeutics Recent Development
Table 88. Sangamo Therapeutics Company Detail
Table 89. Sangamo Therapeutics Business Overview
Table 90. Sangamo Therapeutics Sickle Cell Disease Treatments Product
Table 91. Sangamo Therapeutics Revenue in Sickle Cell Disease Treatments Business (2018-2023) & (US$ Million)
Table 92. Sangamo Therapeutics Recent Development
Table 93. Acceleron Pharma Company Detail
Table 94. Acceleron Pharma Business Overview
Table 95. Acceleron Pharma Sickle Cell Disease TreatmentsProduct
Table 96. Acceleron Pharma Revenue in Sickle Cell Disease Treatments Business (2018-2023) & (US$ Million)
Table 97. Acceleron Pharma Recent Development
Table 98. Arena Pharmaceuticals Company Detail
Table 99. Arena Pharmaceuticals Business Overview
Table 100. Arena Pharmaceuticals Sickle Cell Disease TreatmentsProduct
Table 101. Arena Pharmaceuticals Revenue in Sickle Cell Disease Treatments Business (2018-2023) & (US$ Million)
Table 102. Arena Pharmaceuticals Recent Development
Table 103. Alnylam Pharmaceuticals Company Detail
Table 104. Alnylam Pharmaceuticals Business Overview
Table 105. Alnylam Pharmaceuticals Sickle Cell Disease TreatmentsProduct
Table 106. Alnylam Pharmaceuticals Revenue in Sickle Cell Disease Treatments Business (2018-2023) & (US$ Million)
Table 107. Alnylam Pharmaceuticals Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sickle Cell Disease Treatments Market Share by Type: 2022 VS 2030
Figure 2. Infection Prevention with Vaccination and Antibiotics Features
Figure 3. Blood Transfusion Features
Figure 4. The Medication Hydroxycarbamide Features
Figure 5. A Transplant of Bone Marrow Cells Features
Figure 6. Global Sickle Cell Disease Treatments Market Share by Application in 2022 & 2030
Figure 7. Hospitals Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Sickle Cell Disease Treatments Report Years Considered
Figure 12. Global Sickle Cell Disease Treatments Market Size (US$ Million), Year-over-Year: 2018-2030
Figure 13. Global Sickle Cell Disease Treatments Market Size, (US$ Million), 2018 VS 2022 VS 2030
Figure 14. Global Sickle Cell Disease Treatments Market Share by Region: 2022 VS 2030
Figure 15. Global Sickle Cell Disease Treatments Market Share by Players in 2022
Figure 16. Global Top Sickle Cell Disease Treatments Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Disease Treatments as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Sickle Cell Disease Treatments Revenue in 2022
Figure 18. North America Sickle Cell Disease Treatments Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 19. North America Sickle Cell Disease Treatments Market Share by Country (2018-2030)
Figure 20. United States Sickle Cell Disease Treatments Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 21. Canada Sickle Cell Disease Treatments Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 22. Europe Sickle Cell Disease Treatments Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 23. Europe Sickle Cell Disease Treatments Market Share by Country (2018-2030)
Figure 24. Germany Sickle Cell Disease Treatments Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 25. France Sickle Cell Disease Treatments Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 26. U.K. Sickle Cell Disease Treatments Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 27. Italy Sickle Cell Disease Treatments Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 28. Russia Sickle Cell Disease Treatments Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 29. Nordic Countries Sickle Cell Disease Treatments Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 30. Asia-Pacific Sickle Cell Disease Treatments Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 31. Asia-Pacific Sickle Cell Disease Treatments Market Share by Region (2018-2030)
Figure 32. China Sickle Cell Disease Treatments Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 33. Japan Sickle Cell Disease Treatments Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 34. South Korea Sickle Cell Disease Treatments Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 35. Southeast Asia Sickle Cell Disease Treatments Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 36. India Sickle Cell Disease Treatments Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 37. Australia Sickle Cell Disease Treatments Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 38. Latin America Sickle Cell Disease Treatments Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 39. Latin America Sickle Cell Disease Treatments Market Share by Country (2018-2030)
Figure 40. Mexico Sickle Cell Disease Treatments Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 41. Brazil Sickle Cell Disease Treatments Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 42. Middle East & Africa Sickle Cell Disease Treatments Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 43. Middle East & Africa Sickle Cell Disease Treatments Market Share by Country (2018-2030)
Figure 44. Turkey Sickle Cell Disease Treatments Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 45. Saudi Arabia Sickle Cell Disease Treatments Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 46. AstraZeneca Revenue Growth Rate in Sickle Cell Disease Treatments Business (2018-2023)
Figure 47. Eli Lilly Revenue Growth Rate in Sickle Cell Disease Treatments Business (2018-2023)
Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Sickle Cell Disease Treatments Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Sickle Cell Disease Treatments Business (2018-2023)
Figure 50. Pfizer Revenue Growth Rate in Sickle Cell Disease Treatments Business (2018-2023)
Figure 51. Baxter Revenue Growth Rate in Sickle Cell Disease Treatments Business (2018-2023)
Figure 52. Emmaus Life Sciences Revenue Growth Rate in Sickle Cell Disease Treatments Business (2018-2023)
Figure 53. Bluebird Bio Revenue Growth Rate in Sickle Cell Disease Treatments Business (2018-2023)
Figure 54. Global Blood Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatments Business (2018-2023)
Figure 55. Sangamo Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatments Business (2018-2023)
Figure 56. Acceleron Pharma Revenue Growth Rate in Sickle Cell Disease Treatments Business (2018-2023)
Figure 57. Arena Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatments Business (2018-2023)
Figure 58. Alnylam Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatments Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Industry Market Size
